from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0016c/pbpA

LFCtreatmentdescriptionclass of inhibitor

-1.293

Amikacinug/mL Amikacintranslation

-1.951

Cap5-10ug/mL Capreomycintranslation

-2.005

Rox10-50 ug/mL Roxithromycintranslation

-0.348

SM2-5 ug/mL Streptomycintranslation

-1.705

Tet5-10 ug/mL Tetracyclinetranslation

-0.313

Rif0.2-5ug/mL Rifampicintranscription

-0.273

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.808

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.513

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.190

CPZ10-50 ug/mL Chlorpromazinerespiration

0.732

Clofazimine10-13 ug/mL Clofaziminerespiration

0.800

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.173

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.143

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.540

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.575

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.245

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.502

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.448

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.868

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.577

KCN5-20 ug/mL Potassium cyaniderespiration

0.517

NaN30.2-2 mM Sodium aziderespiration

0.834

Nigericin50 uM Nigericinrespiration

-0.175

TRC10-150 ug/mL Triclosanrespiration

-0.897

TRZ10-25 ug/mL Thioridazinerespiration

-1.559

Valinomycin0.5-10 uM Valinomycinrespiration

1.203

ZnSO42 mM ZnSO4respiration

-0.558

menadione6-10 ug/mL Menadionerespiration

-0.384

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.361

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.474

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.074

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.548

NRP_1Non-replicating persistence stage 1dosRassociated

0.218

Amp0.2mg/mL AmpicillincellWall

0.059

Cephalexin20-100 ug/mL CephalexincellWall

0.427

Cerulenin0.32-5 ug/mL CerulenincellWall

0.093

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.308

EMB10-20 ug/mL EthambutolcellWall

0.179

Eta12-40 ug/mL EthionamidecellWall

-0.143

INH0.2-0.4 ug/mL IsoniazidcellWall

0.120

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.042

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.840

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.120

BZA0.12 mg/mL BenzamidearomaticAmides

0.242

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.264

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.065

H2O24 mM hydrogen peroxideDNAdamaging

-0.431

Levo10 ug/mL LevofloxacinDNAdamaging

0.222

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.346

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.661

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.078

UVUV-irradiationDNAdamaging

-0.153

ARP41-4 ug/mL Antitubercular compound ARP4?

0.297

Antimycin12.5-50 ug/mL Antimycin A?

0.940

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.083

PA_110-50 ug/mL Antitubercular compound PA-1?

0.168

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.040

PA8240.2-2 ug/mL PA-824?

-0.282

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.063

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.369

Verapamil50 uM Verapamil?

0.711

mercaptoethanol2 mM 2-Mercaptoethanol?

1.262

methoxatin10-20 ug/mL Methoxatin?